The prophylaxis required to control an epidemic of Streptococcus pyogenes throat infection in a junior detention centre has been reported. In a further epidemic an attempt was made to determine the minimum amount of penicillin required to control the outbreak. Oral penicillin (0-5 g) given as a single daily dose for 10 days to all boys after entry proved effective.
Introduction
We previously described an epidemic of acute tonsillitis associated with Streptococcus pyogenes in a junior detention centrel where boys aged [14] [15] [16] [17] 
Materials and methods
Tonsillitis was diagnosed clinically, using criteria previously described.' Boys who developed acute tonsillitis were treated as before with intramuscular penicillin, 0-6 g twice a day until symptoms cleared and then oral penicillin, 0 25 g four times a day for 10 days. Erythromycin 0 25 g four times a day was given if there was a history of penicillin allergy.
The following prophylactic regimens were used: from 1 Aug 1978 to 30 Nov 1978 10 g phenoxymethylpenicillin was given in a single dose on day of entry to the centre; from 1 Dec 1978 to 31 Aug 1979 0 25 g in a single dose each day for 10 days after admission; and from 1 Sept 1979 to 31 Aug 1980 0 5 g in a single dose each day for 10 days after admission.
Results
We began by giving penicillin as a single oral dose of 10 g to all boys on entry to the centre, but it was soon apparent that this was having only a partial effect on the high rate pf attack (14 7%). After 16 weeks the dose was increased to 0-25 g a day for 10 days, a regimen which continued for 40 weeks. The rate of infection fell slightly (10-1%), but showed no sign of returning to the pre-epidemic basal level. The dose was increased to 0 5 g a day for 10 days, resulting in a gradual decline to a very low rate (2-1%) (see figure) . Two boys developed acute rheumatism (Jones's criteria) during the study period. 
Discussion
From our previous work we knew that the epidemic of tonsillitis we described was not controlled by the treatment of cases and carriers alone and that full penicillin prophylaxis to all boys on entry was essential. This regimen entailed giving penicillin four times a day; this was difficult to administer and was stopped in 1978, when the epidemic seemed to be under control. Though these measures appeared to be effective, we were unable to claim with certainty that the improvement was ;anything more than fortuitous. A further epidemic began within eight weeks of stopping the prophylaxis (March 1978), which made it more likely that the control we had reported had resulted from penicillin prophylaxis.
This new epidemic presented an opportunity to try to determine the minimum amount of prophylactic penicillin required for control. From our results 0 5 g oral phenoxymethylpenicillin given daily to all boys for 10 days after entry seemed effective; when administered at breakfast and before dispersal to their various activities this was not unduly disruptive.
Four cases of rheumatic fever occurred in our first survey and there were two further cases during this epidemic. Since the incidence of rheumatic fever in the United Kingdom is now believed to be very low, these attacks highlight the need to control epidemics of tonsillitis in closed communities.
Once again we found a sluggish response to prophylaxis. From our previous experience, perhaps we should have foreseen that it would take time to bring the epidemic under control. We do not know whether we could have achieved a quicker response by treating all boys who were in the centre at the height of the epidemic with oral penicillin, but this would seem likely.
There may well be a difference between controlling epidemics in closed communities, such as detention centres, which have a changing population, and semi-closed communities, such as boarding schools, which have a more fixed population. Gastanaduy et al2 recently reported an epidemic in a semi-closed community of 300 people that was brought under control in three -or four months by the administration of intramuscular penicillin or oral antibiotics (phenoxymethylpenicillin or erythromycin) to cases and carriers.
We have already suggested that adolescent boys may be particularly prone to Streptococcus pyogenes infections. Bringing together boys of this age group into closed communities will compound the problem, especially if the population is always changing. We do not have figures from other detention centres, but we are told that sore throats are very common. We suspect that our experience at Kirklevington is not unique and in the relatively socially deprived group of boys in detention centres the risk of developing rheumatic fever may well be higher than in the general population.
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Patients, methods, and results
Twenty-nine patients (16 men, 13 women) aged 18-59 (mean 42) who had received regular haemodialysis for nine to 143 (mean 69) months, entered the study. All were taking iron supplements (Ferrogradumet) orally once daily and none had received folic acid, cobalt chloride, androgens, or a blood transfusion within the preceding six months. The patients were divided into two groups of similar size matched for age, sex, and haemoglobin concentration. Group 1 received folic acid 5 mg daily and group 2 a matching placebo. After six months the groups crossed over, group 1 receiving placebo and group 2 folic acid for a further six months. Haemoglobin concentration and mean corpuscular volume were measured monthly by using a Coulter counter. Serum and red cell folate concentrations were measured at entry and at six and 12 months using a competitive binding assay (Becton Dickinson folate radioassay kit). The patients were seen monthly and completed a questionnaire regarding symptoms and blood loss, grading them as "none," "slight," or "troublesome" (scored 0, 1, or 2 in the analysis).
The significance of changes in haematological variables was measured using non-parametric regression analysis.
Six patients failed to complete the 12 months' trial. Two were withdrawn for transfusion, one after five months' treatment with placebo and the other after six months' treatment with folic acid. Four further patients were withdrawn while taking placebo; one because of sleeplessness, one headache and nausea, one penile irritation, and one worsening psoriasis. Red cell and serum folate concentrations were normal in all patients at entry. They rose significantly during treatment with folic acid and not during placebo periods, confirming compliance with trial medication. The. order in which the treatments were given did not appear to contribute to the treatment effect. Blood loss reported during the treatment periods was similar. The mean haemoglobin concentration on entry was 8-0 g/dl. During treatment with folic acid there was a mean fall of 0-38 g/dl and a mean rise during placebo treatment of 0-25 g/dl. This difference is not significant (p > 0-O5).
The 950 confidence limits for the difference between folic acid and placebo are-1-49 and 0-23, corresponding to a fall of 1-49 g/dl on folate to a fall of 0-23 g/dl on placebo. Changes in mean corpuscular volume did not differ significantly. Symptoms of nausea, headache, vivid dreams, agitation, and irritability were slightly more common during treatment with folic acid, and anorexia, blurred vision,-and sleep disturbance more common during treatment with placebo. None of these differences approached significance. The results were essentially unaltered by including data from the six patients withdrawn from the trial.
Comment
This study has shown no benefit from six months' treatment with folic acid and indeed a slight fall in haemoglobin concentration occurred during treatment with folic acid. In addition, there was a weak association with nausea, headache, vivid dreams, agitation, and irritability, symptoms that have been ascribed to folic acid previously.4
We therefore see no justification for the use of folic acid supplements for adequately nourished patients receiving regular haemodialysis. 
